NEW YORK, Feb. 11, 2014 /PRNewswire/ -- Pomerantz LLP
is investigating claims on behalf of investors of NanoViricides,
Inc. ("NanoViricides" or the "Company")(NYSE MKT: NNVC). Such
investors are advised to contact Robert S.
Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext.
237.
The investigation concerns whether NanoViricides and certain of
its officers and/or directors have violated Sections 10(b) and
20(a) of the Securities Exchange Act of 1934.
On Tuesday, February 11, 2014, a
report was published on Seekingalpha.com website questioning the
integrity of the company and its officers. The article in
part stated that, "NNVC shareholders seem unaware of [an]
incriminating must-read document, written by a company insider
and supporter, which outlines countless examples and allegations of
NNVC managers Seymour and Diwan abusing shareholders and looting
the company."
On this news, shares fell $1.42 per share to $3.00 or more than 32.13%, on February 11, 2014.
The Pomerantz Firm, with offices in New York, Chicago, San
Diego and Florida, is
acknowledged as one of the premier firms in the areas of corporate,
securities, and antitrust class litigation. Founded by the late
Abraham L. Pomerantz, known as the
dean of the class action bar, the Pomerantz Firm pioneered the
field of securities class actions. Today, more than 70 years later,
the Pomerantz Firm continues in the tradition he established,
fighting for the rights of the victims of securities fraud,
breaches of fiduciary duty, and corporate misconduct. The Firm has
recovered numerous multimillion-dollar damages awards on behalf of
class members. See www.pomerantzlaw.com.
CONTACT:
Robert S.
Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com
SOURCE Pomerantz LLP